Gyre Therapeutics, Inc. Interest Expense, Related Party
Gyre Therapeutics, Inc. (GYRE) reported Interest Expense, Related Party of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2017-03-08
- Gyre Therapeutics, Inc. interest expense, related party for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Gyre Therapeutics, Inc. interest expense, related party for the quarter ending 2016-09-30 was $0.00.
- Gyre Therapeutics, Inc. interest expense, related party for the quarter ending 2016-06-30 was $0.00.
- Gyre Therapeutics, Inc. interest expense, related party for the quarter ending 2016-03-31 was $0.00.
- Gyre Therapeutics, Inc. interest expense, related party for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Gyre Therapeutics, Inc. interest expense, related party for fiscal 2015 was $1.50M.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 3 month as first filed | Interest Expense, Related Party 6 month | Interest Expense, Related Party 6 month as first filed | Interest Expense, Related Party 9 month | Interest Expense, Related Party 9 month as first filed | Interest Expense, Related Party 12 month | Interest Expense, Related Party 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $0.00 derived: sum of 2 quarters · filed 2017-03-08 | $0.00 derived: sum of 3 quarters · filed 2017-03-08 | $0.00 10-K · filed 2017-03-08 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | $1.40M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | $1.40M derived: sum of 3 quarters · filed 2017-03-08 | $1.40M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | $1.40M derived: sum of 2 quarters · filed 2017-03-08 | $1.40M derived: sum of 3 quarters · filed 2017-03-08 | $1.40M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2015-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $1.40M derived: sum of 2 quarters · filed 2017-03-08 | $1.40M derived: sum of 3 quarters · filed 2017-03-08 | $1.50M 10-K · filed 2017-03-08 | $100.00K 10-K · filed 2016-03-09 | |||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $39.00M 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $100.00K 10-Q · filed 2016-11-03 | $96.00M 10-Q · filed 2015-11-05 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | $39.00K 8-K/A · filed 2015-10-23 | $0.00 10-Q · filed 2016-08-04 | $39.00K 8-K/A · filed 2015-10-23 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |